Protagonist Therapeutics Inc. (PTGX) Gained 10.91% or 2.1 To Price $21.33 On Monday


Protagonist Therapeutics Inc. (PTGX) gained 10.91% or 2.1 to $21.33. It is close to 131040 shares traded, which is 118.78% compare to the average total volume 110320. The market cap of PTGX is $436.77 million. The year to date change is -9.08%. The 52 week price range is from $8.0 to $21.68. Price of PTGX have changed 1.64% during last week. It have changed -5.32% over last month, 28.63% over last 3 months, 41.29% over last 6 months and -3.71% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for PTGX is 19.15. It is -10.22% below current price. The 200-day Moving Averages for PTGX is 14.66. It is -31.27% below current price. The 52-week High is 21.68. It is 1.64% from the current price. The 52-week Low is 8.0. It is -62.49% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of PTGX is 4.48 on 2018-01-12. Short % to float is 2.42%. There are some statistics of PTGX. It is has market cap $436.77 million. The share outstanding is 20.48 million. The average volume is 110320. The revenue is 8.78M. The percent of top 15 Institution holding is 54.70%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of PTGX is -56.56%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of PTGX is -41.46%.


Tags:

Share this post